Title{1} HYPOfractionated Radiation Therapy comparing a standard radiotherapy schedule (over three weeks) with a novel one week schedule in Adjuvant breast cancer: An open-label randomised controlled study (HYPORT- Adjuvant)
Trial Registration{2a and 2b} The trial has been registered at the Clinical Trial Registry of India (CTRI) vide registration number: CTRI/2018/12/016816 as well as the clinical trial.gov website at NCT03788213.
Protocol version {3} 6.0 dated 8th July 2019
Funding {4} Intramural funding from Tata Medical Center Extramural funding from Nag Foundation Additional extramural funding sought from National Cancer Grid of India
Author Details {5a} Dr Sanjoy Chatterjee, Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal, India, 700156 Dr Santam Chakraborty, Department of Radiation Oncology, Tata Medical Center, Kolkata, West Bengal, India, 700156 Dr Selvamani Backianathan, Department of Radiation Oncology, Christian Medical College, Vellore, Tamil Nadu, India 632004 Dr Punita Lal, Department of Radiation Oncology, Sanjay Gandhi Post Graduate Insitute of Medical Sciences, Lucknow, Uttar Pradesh, India 226014
Name and Contact Information of Trial Sponsor {5b} Tata Medical Center, 14 MAR (E-W), New Town, Action Area III, Kolkata, West Bengal 700156. Phone: 91-3366057402
Role of Sponsor {5c} The Sponsor (Tata Medical Center) is responsible for the trial conduct, reporting and oversight under the guidance of the Institutional Review Board. The trial design was done in collaboration with the other institutes mentioned above. Extramural funding has been obtained from the Nag Foundation for an acute toxicity substudy. The Nag foundation have no role in the study design as the collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication